Stevens-Johnson Syndrome Antimicrobial

计划入组 1 人 · 首次发布于 2009 年 2 月 13 日

Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye

计划入组 31 人 · 首次发布于 2011 年 12 月 8 日

Meibomian Gland Probing in the Sub-Acute Phase of Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

计划入组 30 人 · 首次发布于 2021 年 12 月 6 日

OCTR lymphocytes(Johnson & Johnson)

H3 receptor antagonists(Johnson & Johnson)

RWJ 445167 prodrugs (Johnson & Johnson)

Ash Stevens LLC

United States

Johnson & Johnson

United States

Johnson & Johnson Ltd.

United Kingdom

Stevens-Johnson Syndrome: Understanding Medication Triggers, Timing, and the Critical Window for Diagnosis

Pandorum Technologies Secures $18M Series B to Advance Exosome-Based Regenerative Therapies

Scinai to Acquire Pincell, Advancing Novel Antibody Treatment for Severe Skin Disorders